Logo

Our Mission

is to raise funds to support breast cancer research, clinical trials, education, and patient care.

Donate

Our Approach is Simple:

it starts with you.

Feature Trial

LuMIERE: A Phase 1/2, Multicenter, Open-label, Non-randomized Study to Investigate Safety and Tolerability, Pharmacokinetics, Dosimetry, and Preliminary Activity of [177Lu]Lu-FAP-2286 in Participants with an Advanced Solid Tumor

Breaking it down:

Can we use an experimental agent to deliver radiation to cancer cells that have fibroblast activation protein (FAP)?

Eligibility Criteria:

  1. Are you 18 years or older?
  2. Has your metastatic cancer progressed from prior treatments?

Trial:

  • Phase 1: Dose Escalation. Up to 30 patients with solid tumors. A single dose of 177Lu-FAP-2286, is administered IV every 6 weeks for a maximum of 6 weeks.
  • Phase 2: Specific Solid Tumors. Up to 192 participants treated with 177Lu-FAP-2286, every 4 weeks, in tumor-specific participant groups in monotherapy and in combination with chemotherapy.

Drugs used:

  • 68Ga-FAP-2286 (radioactive tracer)
  • 177Lu-FAP-2286 (radionuclide therapy, using the radioactive isotope lutetium-177)

Locations and Contacts:

23 locations through-out the United States, include Pittsburgh.

  • Carol Glock M.Ed
    Phone: 412-680-6496
  • Cortney Montgomery BSN, RN, CCRP, CBCN
    Phone: 412-641-1840

Your Contribution...

Assists breast cancer clinical trial patients with the added cost for transportation, meals and child care.
medicine
Provides educational opportunities for breast cancer physicians to attend a symposium about current clinical trials.
Educates the general public on breast cancer prevention, detection, treatment and clinical trials.

Feature

Updates

Allegheny Health Network currently has 13 Active Breast Cancer Clinicals Trials

More Details

Wellness Support Group

Update

When:
1 pm - 3 pm
Sunday, Nov 23, 2025
Where:
Panera Bread in Wilkins Twp
3432 William Penn Highway Pittsburh, PA

Gingerbread House Display

Update

🎄 Come See Our Gingerbread House at the City County building- REAR 🍬

Starting Saturday, November 22!

✨ Donate while you visit, and we’ll send you a festive Certificate of Donation (with an adorable gingerbread design) to say thank you for your support.

Vote

What We Do

Update

donate

Community Outreach Programs

  • Learn 5 Strategies for Prevention and Treatment of Breast Cancer
  • Why Me, Cancer is Only One Chapter of a Person’s Life
  • Benefits of Participating in a Breast Cancer Clinical Trial
Breast cancer is the most commonly occurring cancer, and the second most common cause of cancer deaths in women in the United States.
(National Cancer Institute, 2017)

Press

Life-Changeing

A Life Changing Addition for One Pennsylvania Family

The Glock Foundaton is honored to have contributed monies to Canine Service Pals along with the Young Women’s Breast Cancer Awareness Foundation to bring home Oreo a trained service dog exclusively for Cara Snyder’s family.

I Had Cancer Podcast - Investigational Drug Eliminates Breast Cancer

Carol discovered a walnut-size lump in her breast and was diagnosed with inflammatory breast cancer, which is rare and aggressive and carries a 20 percent chance of survival. Carol talks about how a clinical trial at AHN helped her beat the odds.

Living Proof: Allegheny Health Network Together with Johns Hopkins

Carol Glock is featured in an Allegheny Health Network and Johns Hopkins living proof commerical.

If you want to discuss clinical trials or schedule a community outreach presentation please contact us at:

Phone: (412) 680-6496Contact us

Affiliations

AHN
NSABP
BPP
Face2Face
KJ
BreastCancerTrialsOrg